Distinguished Scientist Merck & Co., Inc. Rahway, New Jersey
In the recent years there has been an increased interest in the delivery of peptides via the oral route of administration. This presentation will discuss interesting biopharmaceutics questions based on data from early clinical studies of an oral macrocyclic peptide drug development candidate.
Learning Objectives:
Upon completion, participants will be able to identify challenges related to oral peptide delivery.
Upon completion, participants will gain better understanding of recent developments in the oral peptide delivery space.
Upon completion, participants will be able to understand areas for future biopharmaceutics research for oral peptides.
